VIDEO

Volume 1 - Issue 1

15 years of infliximab – From episodic treatment to therapeutic drug monitoring

VIDEO

Volume 1 - Issue 2

Individual variability in infliximab excretion and elimination

VIDEO

Volume 1 - Issue 3

How do the different TDM assays differ in clinical use?

VIDEO

Volume 1 - Issue 4

In what clinical scenarios might I consider performing TDM?

VIDEO

Volume 1 - Issue 5

When should I not use TDM?

VIDEO

Volume 1 - Issue 6

When in relation to the TNF-α antagonist’s dose should I perform TDM?

VIDEO

Volume 1 - Issue 7

In the presence of loss of response, can you help me interpret TDM results?

VIDEO

Volume 1 - Issue 8

In the presence of loss of response, what should I do if my patient has a low infliximab level?

VIDEO

Volume 1 - Issue 9

In the presence of loss of response, what should I do if my patient has a high infliximab level?

VIDEO

Volume 1 - Issue 10

In the presence of loss of response, if I change the dose of infliximab, should I repeat TDM? If so, when?

VIDEO

Volume 1 - Issue 11

In the presence of loss of response, what is the advantage of TDM to the healthcare provider?

VIDEO

Volume 1 - Issue 12

In the presence of loss of response, what is the advantage of TDM to the patient?